Since anatomic MRI is presently not able to directly discern neuronal loss in Parkinson's Disease (PD), studying the associated functional connectivity (FC) changes seems a promising approach toward developing non-invasive and non-radioactive neuroimaging markers for this disease. While several groups have reported such FC changes in PD, there are also significant discrepancies between studies. Investigating the reproducibility of PD-related FC changes on independent datasets is therefore of crucial importance.
Introduction
Although Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, its diagnosis is still difficult, especially in the early premotor stages, as it is mainly based on clinical evidence. To date, there is still no unique standard diagnostic test for PD, despite the intense research efforts to develop accurate biomarkers based on blood tests or imaging scans. The best current objective tests for PD evaluate dopaminergic function in the basal ganglia by using various PET or SPECT radiotracers (e.g. DaTSCAN) . But these tests use radioactive substances, are performed only in specialized imaging centers and can also be very expensive. Moreover, the loss of dopaminergic nigro-striatal neurons is a delayed pathological event in the evolution of the disease, corresponding to Braak stages III-IV.
On the other hand, conventional (CT or MRI) brain scans of PD patients usually appear normal or with minor non-specific changes, so that conventional imagining techniques are only useful for ruling out other diseases that can be secondary causes of parkinsonism.
Therefore, since anatomic MRI is presently not able to directly discern (dopaminergic) neuronal loss in PD [Tuite et al., 2013] , studying the associated functional connectivity (FC) changes seems to be a promising approach toward developing non-invasive and non-radioactive neuroimaging markers for this disease.
While many groups have reported such FC changes in PD (see Supplementary Table 1 for a list of such studies), an in-depth analysis of existing literature revealed significant discrepancies between studies. Investigating the reproducibility of PD FC changes on independent datasets is therefore of crucial importance.
A comprehensive review and analysis of the literature related to resting-state fMRI studies of Parkinson's disease is out of the scope of the present paper [Gottlich et al., 2013; Long et al., 2012; Skidmore et al., 2013; Baudrexel et al., 2011; Wu et al., 2011; Kwak et al., 2010; Kwak et al., 2012; Helmich et al., 2010; Helmich et al., 2011; Luo et al., 2014; Yu et al., 2013; Hacker et al., 2012; Kurani et al., 2015; Baggio et al., 2015; Esposito et al., 2013; Szewczyk-Krolikowski et al., 2014; Tessitore et al., 2012; Sharman et al., 2013; Wu et al., 2012; Chen et al., 2015; Wen et al., 2013] (Supplementary Table 1 ; see also the review by [Tahmasian et al., 2015] ). We only mention some important discrepancies of reported functional connectivity changes in PD. Due to the crucial importance of the striatum in PD, we first discuss some discrepancies involving striatal seeds [Tahmasian et al., 2015] :
• Contrary to [Hacker et al. 2012] , [Helmich et al. 2010 ] observed no significant difference in caudate functional connectivity in PD.
• On the other hand, contrary to the study [Helmich et al., 2010] , [Luo, Song, et al. 2014] did not observe increased FC of the anterior putamen.
• In contrast to [Hacker et al., 2012] , [Luo, Song, et al. 2014 ] did not find a FC decrease between the striatal seeds and the brainstem.
There are also discrepancies involving non-striatal seeds. For example, [Wu et al., 2011] found disrupted FC between the pre-SMA and the left putamen, as opposed to [Helmich et al., 2010] , who did not find a decreased FC between the putamen and pre-SMA in PD.
Since the motor symptoms are the most striking clinical manifestations in PD, many rs-fMRI studies of PD concentrate on the sensorimotor system, including the basal ganglia, while disregarding any other FC changes. On the other hand, other more unbiased studies tried to determine a more global picture of the FC changes in PD. Some even tried to develop a classifier for the disease based on rs-fMRI data [Long et al., 2012; Skidmore et al., 2013; SzewczykKrolikowski et al., 2014; Chen et al., 2015] , but most studies were not validated on independent datasets.
There are also some gross discrepancies involving even the sign of the main FC changes in PD. For example, [Luo et al. 2014] found only decreased FC in early stage PD, whereas most studies also find FC increases.
The general picture one gets from the literature is complex and at times somewhat confusing due to the numerous discrepancies. Of course, these discrepancies could be due to the different disease stages analyzed, to the inherent functional heterogeneity of the disease, as well as to technical differences, or to the differences in the complex data (pre)processing workflows. Therefore, it is crucial to use the same data processing workflow to check the reproducibility of PD-related FC changes on as many independent datasets as possible.
In this work, we report a comparison between three different datasets obtained by completely independent research groups (see Table 1 ). More precisely, we acquired resting-state scans for 43 Romanian subjects (27 patients and 16 normal controls, with 2 replicate scans per subject) and compared the observed functional connectivity changes with those obtained in two independent datasets, one made available by the PPMI consortium in the US (91 patients, 18 controls) and a second one by the group of Tao Wu in China (20 patients and 20 normal controls).
Our initial findings revealed the non-reproducibility of the FC changes across datasets. Of course, these differences could indicate disease heterogeneity, but they could also be due to technical differences. To better distinguish between these two possibilities, we devised a method to directly check for disease heterogeneity using random splits of a single dataset. More precisely, since each subject in the NEUROCON study was scanned twice, we can construct two homogeneous dataset splits simply by using (different) scans of the same subjects. Additionally, two heterogeneous dataset splits can be obtained by placing different subjects (with all their scans) in each split. Reproducibility across the heterogeneous splits would indicate disease homogeneity, while nonreproducibility would imply disease heterogeneity. (In both cases, we would have to observe reproducibility across the homogeneous splits, due to their construction.) Technical differences cannot be blamed for non-reproducibility across the heterogeneous splits, since by construction all splits have been obtained under identical technical conditions.
In the case of PD, we observed reproducibility only across the homogeneous dataset splits, with non-reproducibility across the heterogeneous ones. On the other hand, repeating the analysis for a different contrast (eyes open versus eyes closed for normal subjects) revealed reproducibility across both the homogeneous as well as the heterogeneous splits. We interpret this as an indication of heterogeneity of PD-related global FC changes in different patients and patient cohorts.
Despite such non-reproducible global changes, it might be in principle possible that only a very few brain region pairs might still reproducibly differentiate PD patients from controls. Therefore, we also studied the reproducibility of the FC changes that best differentiate PD from controls by computing the significance of brain region pairs with p-values that are significant w.r.t. all datasets. The FC changes that best differentiate PD from controls turned out to be dataset-specific too and most likely reflect the predominant changes in that particular patient cohort.
Although not ideal, this is the first study investigating the reproducibility of functional connectivity changes in Parkinson's disease on more than 2 datasets. Given the paucity of publicly available rsfMRI PD datasets, we advocate the critical importance of data sharing for enabling the discovery of reproducible rs-fMRI biomarkers of PD. 
Materials and Methods

Datasets
Three resting-state fMRI datasets of Parkinson's disease were compared in this study (see also Table 1 for the main patient characteristics and the numbers of scans in each study):
-the NEUROCON rs-fMRI study of 27 PD patients and 16 normal controls (NC) of the Neurology Department of the University Emergency Hospital Bucharest (Romania),
-a dataset of 20 PD patients and 20 normal controls provided by the group of Tao Wu (China),
The datasets are somewhat similar, except for PPMI, which involved patients with a diagnosis of PD for two years or less and who are not taking PD medications. Most patients from the other two studies have been under treatment (most under levodopa). Still, we argue that our findings were not affected by these differences. Since the datasets were compared in a pairwise manner, any putative discrepancies due to the shorter disease durations in the PPMI dataset would only show up in the NEUROCON-PPMI and Tao Wu-PPMI comparisons, but not in the NEUROCON-Tao Wu comparison. This was not observed in reality.
NEUROCON
Subjects
The NEUROCON study enrolled 27 patients with Parkinson's disease (mean age±SD 68.7±10.6 years) and 16 age-matched normal controls (67.6±11.9 years) with no history of neurological or psychiatric disease. The patients were clinically assessed at the Neurology Department of the University Emergency Hospital Bucharest (Romania) to be in the early or moderate stage of the disease according to the Queen Square Brain Bank (QSBB) clinical criteria and met the EFNS/MDS-ES (European Federation of Neurological Societies/Movement Disorder SocietyEuropean Section) recommendations for diagnosis of Parkinson's disease.
The mean disease duration was 4.6 (±6.5) years for the entire patient cohort and respectively 2.75 (±2.15) years after excluding three patients with particularly long disease durations (over 10 years: 11, 16 and 32 years, respectively). Despite the longer disease durations, the above-mentioned 3 patients met the criteria for moderately advanced disease (H&Y stage 2) and thus were included in the study.
The mean Hoehn and Yahr (H&Y) score [Hoehn and Yahr, 2001 ] was 1.93 (±0.33) and respectively 1.92 (±0.35) after excluding the 3 patients with long disease durations. According to the H&Y system, all patients were in an early to moderate stage of disease (stages 1 to 2.5).
The patients' mean score on the motor subset of the Unified Parkinson's Disease Rating Scale (UPDRS) [Fahn, 1986] in the off medication condition was 28.3 (±9.3) for the entire patient cohort and 26.9 (±8.8) after excluding the 3 patients with long disease durations.
The study has been approved by the University Emergency Hospital Bucharest ethics committee in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. All patients gave their informed consent to participate in the study.
Scanning
All subjects underwent two consecutive 8 min fMRI scans in a 1.5-Tesla Siemens Avanto MRI scanner, in an awake resting state with their eyes closed.
Two replicate scans were acquired for each subject to enable the study of the reproducibility and respectively homogeneity of FC changes in PD, as briefly mentioned in the Introduction and discussed at length below. (A single (control) subject could only be scanned once.) The patients were scanned in the "off medication" state, at least 10 hours after intake of the last medication.
The scanning protocol involved an Echo Planar sequence with repetition time (TR) 3480 ms, echo time (TE) 50 ms, axial orientation, voxel size 3.8×3.8×5 mm (without slice gaps), flip angle 90° and number of averages=1. Each resting state session lasted 8.05 min, comprising 137 volumes.
To enable better co-registration to the standard MNI template, high-resolution T1-weighted images were also obtained for all subjects using an MPRAGE sequence (IR method, TR=1940ms, TE=3.08ms, inversion time (IT)=1100ms, voxel size 0.97×0.97×1 mm, number of averages=1). 
Tao Wu
PPMI
Subjects
The patients had a mean Hoehn & Yahr score of 1.72 (SD 0.48), with a mean disease duration (at the time of the scan) of 1.9 years (SD 1.0). All patients had H&Y scores 1 to 2, except for only two, who were classified as H&Y stage 3.
Scanning
The subjects were scanned in 8 different centers, but with a similar protocol on Siemens TrioTrim 3Tesla scanners. Although our functional connectivity computations did not require any particular type of data normalization (as only inter-region correlations are computed, rather than amplitudes), we also considered a subset of scans acquired in a single center (center number 32, with the largest number of PD patient and normal control scans), referred to in the following by the suffix 'center32'.
Preprocessing
All datasets were (pre)processed in a uniform manner. The raw scanner data in DICOM format was converted to NIfTI using dcm2nii (https://www.nitrc.org/projects/dcm2nii/) and further preprocessed using FSL (FMRIB Software Library v5 http://fsl.fmrib.ox.ac.uk/fsl/) as follows: motion correction using MCFLIRT, brain extraction with BET, spatial smoothing (Gaussian kernel FWHM 5mm) and denoising using nonlinear filtering (SUSAN), temporal high-pass filtering (with a cutoff frequency of 1/100 Hz), registration to the standard Montreal Neurological Institute MNI152 template via the anatomical T1 image (more precisely, BBR registration of the BOLD image to the T1 image, followed by 12 DOF linear+nonlinear registration of the latter to the 2mm MNI template). Nonlinear registration was performed at a resampling resolution of 4mm.
Subject motion in scanner
Since subject motion in the scanner has been observed to have significant influence on the functional connectivities computed from rs-fMRI data, despite motion correction (e.g. [Power et al., 2015] ), we also considered subsets of scans with low in-scanner motion (marked by the suffix '0', e.g. 'NC0' and 'PD0' -see also Supplementary Table 2) .
Resting state functional connectivity
In neuroimaging, functional connectivity refers to temporal correlations between spatially remote brain regions [Friston and Buchel, 2003] . It is a rather loosely defined term, since it encompasses many different methods used to reveal the temporal correlations of BOLD activity across the brain. The simplest method consists in computing the correlations between all pairs of regions of a given brain parcellation, but more sophisticated data decomposition methods, such as Independent Component Analysis (ICA) are also used on a large scale. Such data decomposition methods do not assume a given brain parcellation, but instead construct spatial maps grouping voxels with similar (highly correlated) timecourses. (Still, instead of being given a parcellation, such methods need to be provided with a target number of components.)
Brain parcellations
In our study of the reproducibility of functional connectivity changes in PD, we have chosen to use fixed brain parcellations rather than data decomposition methods such as ICA, since the latter are always specific to a particular subject cohort. Running group-ICA on a particular dataset would have the advantage of obtaining a better functional parcellation than a predefined one for that dataset, but that parcellation would also be to a certain extent specific to that dataset (overfitting). The parcellation of this "training dataset" is typically less appropriate for any other independent dataset and would thereby introduce a bias in the analysis. (For example, when comparing 3 different datasets, on which one should we run the group-ICA decomposition? Running it on their union would not solve the problem, since it would overfit the entire union and would probably not work as well for an independent 4 th dataset.)
To avoid these problems, we have chosen to use brain parcellations constructed independently of the datasets under comparison. Of course, this doesn't disallow the use of functional brain parcellations obtained e.g. by group-ICA on a completely independent set of subjects. And indeed, we also use a functional parcellation ('Stanford' [Shirer et al., 2011] ) obtained in such a manner.
Moreover, to compensate for potential biases of any specific parcellation, we extended our analyses to a number of 13 different parcellations, some of which are progressive refinements of other parcellations (for instance, Craddock950 is a parcellation with 950 regions that refines the 500 region Craddock500 parcellation; the same holds for the Shen* parcellations). Table 2 summarizes the parcellations used in this study. [Shen et al., 2013] 278 OASIS [Marcus et al., 2007 ] 97
Power [Power et al., 2011] 264 spherical regions with a 10mm radius Gordon_surface [Gordon et al., 2014] 333
Talairach [Talairach and Tournoux, 1988 
PD-related functional connectivity changes
For each dataset, we determined significant PD-related FC changes by applying two-sample t-tests (with unequal sample sizes and unequal variances) to the functional connectivities of all ROI pairs. ROI-pairs with significant group differences (NC versus PD) represent regions whose functional connectivity was found to be significantly different in PD patients in that particular dataset. The main aim of this study is to determine whether these changes are reproducible across datasets, to enable the development of functional imaging biomarkers for PD.
Reproducibility of global functional connectivity changes in PD
Comparison of 3 different PD datasets
We first compared the global PD-related functional connectivity changes across the three independent datasets NEUROCON, Tao Wu and PPMI to check to what extent these changes are reproducible. More precisely, we performed pairwise comparisons for all dataset pairs as follows. For each pair of datasets, we checked the extent to which the PD-related FC changes in one dataset are correlated to the changes in the second dataset. PD-related FC changes were quantified using t-values t(ROI k ,ROI l ) from group comparisons (unpaired two-sample t-tests between NC and PD) of the functional connectivities between pairs of regions of interest FC(ROI k ,ROI l ). Then the reproducibility R ij across the two datasets i and j was determined as the correlation between the corresponding t-values (viewed as a vector over all ROI pairs) for the two datasets:
where
with t i (ROI k ,ROI l ) the t-value corresponding to PD-related FC changes between ROI k and ROI l with respect to dataset i (and similarly for T j ).
For a more intuitive graphical depiction of reproducibility across two datasets, we also constructed the scatter-plot of ROI-pair t-values corresponding to group comparisons in the two datasets (see Figure 2 for an example of such a scatter-plot).
Comparing PD-related FC changes (t-values) in the two datasets amounts to plotting for each ROIpair the t-value in dataset 1 against the t-value in dataset 2. We thereby obtain a scatter-plot with a point for each ROI pair. The comparison of the FC changes in the two datasets thus involves analyzing the distribution of points in the scatter-plot: ideally, perfect reproducibility would entail a diagonal distribution of points in the scatter-plot, corresponding to identical t-values in the two datasets. Figure 7 depicts examples of good reproducibility, while Figure 2 shows cases of nonreproducibility across datasets.
The correlation of t-values for the two datasets R ij = corr(T i ,T j ), as introduced above in (1), can be viewed as an aggregate measure of the reproducibility across the two datasets i and j.
To obtain a more quantitative measure of the statistical significance of such a correlation R ij between datasets, we performed permutation tests of the group labels (NC and PD), independently for the two datasets and computed the p-value of the R ij value as the fraction of permutations for which the dataset correlation w.r.t. the permuted data R ij (p) exceeds the real one (R ij ):
where N is the number of permutations. All our permutation tests involved N=1000 permutations.
Various factors have been mentioned in the literature to affect functional connectivity measures: -subject motion in the scanner [Power et al., 2015] , -global signal regression (with or without) [Murphy et al., 2009; Hayasaka 2013] , -the choice of the parcellation.
To study the influence of these factors on our reproducibility results, we also considered subsets of scans with low in-scanner motion (marked by the suffix '0', e.g. 'NC0' and 'PD0'), repeated our analyses with and without global signal regression and performed the comparisons using all 13 brain parcellations previously mentioned. Since the PPMI data has been acquired in several different imaging centers, we also considered a potentially more homogeneous subset of scans acquired in a single center (center number 32, with the largest number of PD patient and normal control scans), referred in the following by the suffix 'center32'.
Comparison of random splits of the same PD dataset
As already mentioned in the Introduction, the observed lack of reproducibility of global FC changes across datasets could be due to disease heterogeneity, but also to technical differences. To distinguish between these two possibilities, we devised a method to directly check for disease heterogeneity using random splits of a single dataset with replicate scans. Technical differences can then be excluded since all the scans have been acquired under identical technical conditions. More precisely, since in the NEUROCON study we have acquired two replicate scans for each subject, we can construct two homogeneous dataset splits simply by using (different) scans of the same subjects. Additionally, two heterogeneous dataset splits can be obtained by placing different subjects (with all their scans) in each split. In other words, instead of comparing two distinct datasets, we compared two random splits of the same dataset, either:
(a) by placing different subjects in the two splits, with all the replicate scans of a subject in the same split ("split subjects", heterogeneous split), or (b) by placing each replicate scan of the same subject in a different split, so that the two splits contain (different) scans of the same subjects ("split replicates", homogeneous split).
Dataset splits (b) are homogeneous since they both contain scans of the same subjects, while splits (a) are heterogeneous since they contain scans of different subjects. Therefore, reproducibility across the heterogeneous splits would indicate disease homogeneity, while non-reproducibility would imply disease heterogeneity. (In both cases, we would have to observe reproducibility across the homogeneous splits, by construction.) A diagram of our method is shown in Figure 1 .
As in the pairwise comparisons between different datasets, we used permutation tests to compute pvalues of the reproducibility across split datasets, for both the heterogeneous ("split subjects") and the homogeneous ("split replicates") datasets. Due to the random nature of the splits, we repeated the analysis for 5 different random splits of the original data.
The analysis was also rerun for the data with global signal regression. Figure 1 . Using random splits of a dataset with replicate scans to check for disease (group) heterogeneity: (a, right) by placing different subjects (with all their replicate scans) in the two splits ("split subjects") and respectively (b, left) by splitting the replicates of the same subjects in the two splits ("split replicates"). The "split replicates" datasets must show reproducible changes anyway, while non-reproducible changes across the "split subjects" datasets are an indication of disease heterogeneity. (a,b,c,... correspond to subjects, while, for instance, a' and a" are replicate scans for subject a.)
Comparison of random splits of an 'eyes open-eyes closed' dataset
Besides the potentially heterogeneous contrast between PD and normal controls, we also tested our method to a different, potentially more homogeneous contrast: eyes open versus eyes closed resting state in healthy volunteers. We used the Beijing eyes-open-eyes (EO-EC) closed dataset (http://fcon_1000.projects.nitrc.org/indi/IndiPro.html), which involved 48 college students (aged 19-31 years, 24 female) with no history of neurological and psychiatric disorders. Each participant underwent three 8 min resting state scanning sessions: an EC session followed by two sessions counter-balanced across subjects: one EO resting state and one EC resting state session.
The functional images were obtained on a Siemens Trio 3 Tesla scanner using an echo-planar imaging sequence with the following parameters: 33 axial slices, thickness/gap=3.5/0.7 mm, inplane resolution=64×64, repetition time (TR)=2000 ms, echo time (TE)=30 ms, flip angle=90°, field of view (FOV)=200×200mm 2 , 240 volumes per scan. In addition, a 3D T1-weighted MPRAGE image was acquired with the following parameters: 128 sagittal slices, slice thickness/gap=1.33/0 mm, in-plane resolution=256×192, TR=2530 ms, TE=3.39 ms, inversion time (TI)=1100 ms, flip angle=7°, FOV=256×256 mm 2 . Note that the parameters used in this study are quite similar to the ones from the PD datasets, including the scanning time (~8 min), with the exception of the 1.5 Tesla field strength used in the NEUROCON study (all the other studies used 3 Tesla machines).
We repeated our analyses of reproducibility of group changes in functional connectivity on random splits of the Beijing EO-EC dataset on both "split subjects" (heterogeneous) and "split replicates" (homogeneous) datasets using the AAL parcellation. As in the case of PD, permutation tests were employed to compute p-values of the reproducibility across split datasets (we report analysis results for 5 different random splits of the original data). Additionally, we reran the analysis for the data with global signal regression.
Influence of technical factors, preprocessing and parcellation
We also studied the influence on reproducibility of certain key technical factors and preprocessing steps, such as: -the repetition time (TR), -linear vs. nonlinear registration, -global signal regression, -the specific brain parcellation used for evaluating functional connectivity.
The AAL parcellation (which is typical) was used whenever not specified otherwise.
Doubling the TR
To study the influence of the repetition time on reproducibility, we constructed a synthetic dataset with a double TR by leaving out every second time-point from the NEUROCON timeseries data (for each scan and each voxel). We then analyzed with our method the reproducibility of group changes in functional connectivity between the original NEUROCON dataset and the synthetic one with a double TR.
Linear vs. nonlinear registration
To study the impact of registration on reproducibility, we preprocessed the NEUROCON data both with linear and nonlinear registration to the MNI 152 template and determined the reproducibility of group changes in functional connectivity between the two resulting datasets.
Global signal regression
Finally, we also studied the reproducibility of FC changes between the NEUROCON dataset processed with global signal regression and the same dataset processed without global signal regression.
Influence of parcellation
To avoid potential biases of any specific parcellation, we reran our pairwise comparisons between the 3 PD datasets using all 13 different parcellations mentioned above, including functional and anatomic parcellations, as well as refinements with different numbers of ROIs of a given base parcellation (the 'Craddock' and respectively 'Shen' parcellations).
Reproducibility of the differentiating FC changes
The reproducibility analysis performed above involves global functional connectivity changes, i.e changes in the FC of all ROI pairs, not just the ones that differentiate PD from normal controls. Even with non-reproducible global FC changes, it might be in principle possible that only a very few brain region pairs might still reproducibly differentiate PD patients from controls. Therefore, we also studied the reproducibility of the FC changes that best differentiate PD from controls by computing the significance of ROI pairs with p-values that are significant w.r.t. all datasets.
More precisely, for each ROI-pair, we compute the largest (least significant) of the p-values obtained in the 3 datasets (separately for the FC increases and respectively decreases) and sort the ROI-pairs in increasing order of this max(p). The best (most significant) min(max(p)) of these max(p) corresponds to the ROI-pair with the best overall significance with respect to the 3 datasets, as all other ROI-pairs have larger (less significant) p-values with respect to at least one dataset.
Finally, to assess the statistical significance of such a best ROI-pair, we use a permutation test (of the disease labels in each dataset) to check the fraction of random permutations with a more significant (smaller) min(max(p)) than the real data (we performed N=1000 random permutations).
p(min(max(p +
where min(max(p + )) corresponds to FC increases in NC versus PD. A similar relation holds for the FC decreases min(max(p − )).
The analysis was repeated for all 13 parcellations considered in this study (Table 2) .
Results
ROI-pairs with significant group differences (NC versus PD) in functional connectivity were found in all three PD datasets: NEUROCON, Tao Wu and PPMI. However, these changes seem at first sight to be distinct in each dataset. Our main aim in this paper has been to systematically investigate the reproducibility of the PD-related FC changes across independent datasets.
It is perhaps interesting to note that we could develop classifiers with a high cross-validation accuracy on each isolated dataset (data not shown). Such highly accurate classifiers under crossvalidation were also developed in other publications mentioned in Supplementary Table 1 (e.g. [Long et al., 2012; Skidmore et al., 2013] ), but it seems that a high cross-validation accuracy doesn't necessarily entail a high accuracy on independent datasets!
PD-related FC changes are non-reproducible across 3 datasets
The reproducibility of global PD-related functional connectivity changes was determined by pairwise comparisons between three independent datasets: NEUROCON, Tao Wu and respectively PPMI. Figure 2 shows the scatter-plots of ROI-pair t-values (corresponding to the group comparison NC-PD) for the three dataset pairs, indicating a lack of reproducibility of global FC changes in PD. (Perfect reproducibility would correspond to a diagonal distribution of points corresponding to ROI pairs with identical t-values with respect to both datasets.) Moreover, discriminating ROI-pairs situated in the upper right and respectively lower left corners of one plot are not discriminating in the other plots.
NEUROCON-TaoWu
R= −0.146
TaoWu-PPMI R=0.0067 Figure 2 . Scatter-plots of ROI-pair t-values for the three dataset pairs indicate non-reproducibility of global PD-related FC changes For a more quantitative measure of the reproducibility of FC changes between two datasets, we computed the Pearson correlation between t-values (viewed as vectors of over all ROI pairs) with respect to each dataset (values R shown in Figure 2 .) We also estimated the statistical significance (p-values) of these reproducibility measures by permutation tests of the group labels independently for the two datasets - Table 3 shows the reproducibility measure and associated p-value for various pairwise comparisons between the three datasets, without global signal regression. Since in-scanner motion may influence FC measures, we present not only a comparison between the full patient and normal control cohort, but also that corresponding to a subset of scans with low in-scanner motion (denoted by the suffix '0'). Moreover, since PPMI data were acquired at many different centers, we also consider the restriction of the PPMI data to the scans from a single center (suffix 'center32'). Table 4 presents the same results for the data processed with global signal regression. (The AAL parcellation was used in this case, but we also study the influence of the parcellation later on.) A clear lack of reproducibility of global PD-related FC changes is observed in all the three dataset pairs. This is the first study comparing three independent rs-fMRI datasets of PD. The fact that we compare 3 datasets is very important, as it lowers the probability that the lack of reproducibility is due to a dataset that may be "faulty" in some sense -in that case, with 3 datasets we might still observe reproducibility with respect to the remaining dataset pair (which we do not see in reality).
Non-reproducible FC changes in heterogeneous dataset splits indicate disease heterogeneity
The non-reproducibility across 3 datasets mentioned above seems to be due to disease heterogeneity, but it could also be due to technical differences. To exclude the latter possibility, we checked for disease heterogeneity using random splits of a single dataset with replicate scans (NEUROCON), all of which have been acquired under identical technical conditions.
(a) We first constructed random splits by placing different subjects in the two splits, with all the replicate scans of a subject in the same split ("split subjects", heterogeneous splits). Table 5 shows the reproducibility measure and associated p-value for 5 such random splits of the NEUROCON dataset. None of these heterogeneous splits showed reproducible FC changes (p>0.05), regardless of global signal regression (see also Figure 3 ). Figure 3 . Scatter-plots of ROI-pair t-values for a heterogeneous dataset split indicate nonreproducibility of global PD-related FC changes (b) Next, we constructed random splits by placing each replicate scan of the same subject in a different split, so that the two splits contain (different) scans of the same subjects ("split replicates", homogeneous splits). Table 6 shows the reproducibility measure and associated p-value for 5 such random splits of the NEUROCON dataset. All of these homogeneous splits showed reproducible FC changes, regardless of global signal regression (see also Figure 4 ). The observed non-reproducibility in the heterogeneous dataset splits indicates disease heterogeneity, in line with the comparison between the 3 independent PD datasets. As a control, we did indeed observe reproducibility with respect to the homogeneous dataset splits, as expected.
'Eyes Open-Eyes Closed' FC changes are reproducible
The FC heterogeneity of Parkinson's disease is perhaps no surprise to an experienced neurologist, who is routinely facing PD patients with highly variable clinical manifestations. However, does this FC heterogeneity in PD also imply the lack of practical usefulness of rs-fMRI functional connectivity? Are there any other conditions that can be reliably differentiated using resting state functional connectivity? To answer these questions, we applied our approach to a different, potentially more homogeneous contrast, namely that between eyes open and eyes closed resting state conditions in healthy volunteers. Repeating our analysis of reproducibility of FC group changes on random splits of the Beijing eyes open-eyes closed dataset revealed reproducibility (p<0.05) not just in the homogeneous dataset splits (Table 8 and Figure 6 ), but also in the heterogeneous ones (Table 7 and Figure 5 ). This implies that the EO-EC contrast produces more homogeneous and reproducible global FC changes. (Table 9 ). 
Influence of technical factors and preprocessing on reproducibility
We found good reproducibility when changing various technical factors or processing options of the NEUROCON data, such as (see Figure 7) : -doubling the repetition time (TR), -registration (linear versus nonlinear), -global signal regression (with versus without).
This is in line with our conclusion that functional heterogeneity, rather than these technical factors, is the dominating factor behind the lack of reproducibility of FC changes in different rs-fMRI studies of Parkinson's disease.
Doubling the TR R=0.957 Registration (linear vs nonlinear) R=0.8908
Global signal regression (with vs without) R=0.7282 Figure 7 . Reproducibility when changing various technical factors or preprocessing options
We also tested the influence of various rs-fMRI denoising methods on the reproducibility of PDrelated FC changes, such as ICA-FIX Salimi-Khorshidi et al., 2014] , or regression of the mean white matter and/or cerebrospinal fluid signal -none of these denoising methods changed the observed non-reproducibility (data not shown).
Influence of parcellation on reproducibility
We have argued that functional connectivity must be computed with respect to an unbiased parcellation (i.e. one that hasn't been constructed from any of the analyzed datasets). However, any given parcellation has also specific biases that may in principle affect the capacity to discriminate between PD and normal controls -an especially relevant factor is the average size and number of the ROIs. Testing the reproducibility of the PD-related global FC changes using 13 different parcellations, with varying numbers of ROIs (see Table 2 ), revealed a lack of reproducibility regardless of parcellation, or dataset pair (Table 10) . Table 10 . Reproducibility measure and associated p-value for 13 parcellations and all three dataset pairs 
Non-reproducibility of the differentiating FC changes in PD
Despite non-reproducibility of PD-related global FC changes across different datasets, a small number of ROI-pairs that distinguish PD from NC may nevertheless, in principle, show reproducible changes across datasets. To check for this possibility, we studied the reproducibility of the FC changes that best differentiate PD from controls by sorting the ROI-pairs according to their least significance with respect to all datasets. For example, Table 11 shows the ROI-pairs with FC decreases in PD (i.e. positive t-values, corresponding to NC>PD) and max(p) < 0.05 for the Power264 parcellation, without global signal regression. The best ROI-pair has max(p + )=0.0125.
To check whether this min(max(p + )) is statistically significant, we performed permutation tests as described. Table 12 lists these min(max(p ± )) values as well as their associated significance p(min(max(p ± ))) for all 13 parcellations. Unfortunately, no ROI-pair was found at a p<0.05 significance level, although for 3 parcellations out of 13, ROI-pairs with p<0.1 were found (see Table 13 and Figure 8 ). These marginally significant ROI-pairs involve visual-sensorimotor, respectively visual-parietal association areas. 
Limitations
The present study has concentrated on PD-related changes in functional connectivity (loosely viewed as correlations between different regions of interest), rather than changes in fluctuations of the amplitude of the rs-fMRI signal. In a complementary study, [Wu et al., 2015] observed PDrelated changes in ALFF, but with rather limited reproducibility. An in-depth analysis of the reproducibility of amplitude of fluctuations in PD is out of the scope of the present paper.
Discussion
This is the first study investigating the reproducibility of functional connectivity changes in Parkinson's disease on more than two datasets. The fact that our comparison involves three datasets is very important, as it lowers the probability that the lack of reproducibility is due to a problematic dataset -in that case, with 3 datasets we might still observe reproducibility with respect to the remaining dataset pair, something which we do not see in reality.
Our analyses suggest that functional heterogeneity may be a dominating factor behind the lack of reproducibility of functional connectivity changes in different resting state fMRI studies of Parkinson's disease.
This could be due to the heterogeneous multi-lesional topography and progression of the neurodegenerative process, possibly accompanied by variable compensatory functional circuit changes, as well as by changes due to dopaminergic medication [Tahmasian et al., 2015] .
Given the paucity of publicly available rs-fMRI PD datasets, we advocate the critical importance of data sharing for enabling the discovery of reproducible functional imaging biomarkers of PD. All the data from the present study will be made publicly available at http://...
Information Sharing Statement
All data from the present study will be made available in de-identified form at http://...
Supplementary material
Resting-state fMRI studies of Parkinson's disease 
Subject motion in scanner
Since subject motion in the scanner has been observed to have significant influence on the functional connectivities computed from rs-fMRI data, despite motion correction (e.g. [Power et al., 2015] ), we also considered subsets of scans with low in-scanner motion (marked by the suffix '0', e.g. 'NC0' and 'PD0' -see also Supplementary Table II The following Tables show the p-values 
